HilleVax, Inc. (NASDAQ:HLVX – Get Rating) gapped down before the market opened on Wednesday . The stock had previously closed at $21.02, but opened at $20.42. HilleVax shares last traded at $20.51, with a volume of 50 shares.

HilleVax Stock Up 0.1 %

The business's 50 day moving average is $19.37 and its two-hundred day moving average is $14.70. The company has a debt-to-equity ratio of 0.02, a quick ratio of 34.77 and a current ratio of 34.77.

Hedge Funds Weigh In On HilleVax

Hedge funds have recently bought and sold shares of the company. Strs Ohio acquired a new stake in HilleVax in the second quarter worth $32,000. TD Asset Management Inc. acquired a new stake in HilleVax in the second quarter worth $203,000. Frazier Life Sciences Management L.P. acquired a new stake in HilleVax in the second quarter worth $101,493,000. JPMorgan Chase & Co. acquired a new stake in HilleVax in the second quarter worth $76,000. Finally, Alps Advisors Inc. acquired a new stake in HilleVax in the second quarter worth $217,000.

HilleVax Company Profile

HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

Read More

• Get a free copy of the StockNews.com research report on HilleVax (HLVX)
• After Nixing its 13% Dividend, Is Lumen Technologies Okay To Own?
• Cisco Systems Hopes Restructuring Cuts Costs to Drive Revenue
• The Sell-Side Caps Gains In Dick's Sporting Goods
• Want to Get a 10% Dividend Yield, Look Here
• Stock-ing Stuffers: 3 Attractive Stocks Trading Around $10

Receive News & Ratings for HilleVax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HilleVax and related companies with MarketBeat.com's FREE daily email newsletter.